Evidence map›Paper›PMID 34287236›Full record

ArticleBiomimetics (Basel, Switzerland)2021

Biomimetic Leadership for 21st Century Companies.

Edita Olaizola, Rafael Morales-Sánchez, Marcos Eguiguren Huerta

Abstract read
In one paragraph

Article in Biomimetics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Bioinspired Intelligence II.Biomimetics (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Edita OlaizolaPeople Plus! Profit, 08195 Barcelona, Spain.ORCID 0000-0002-7423-8682
Rafael Morales-SánchezDepartment of Management and Marketing, Universidad Pablo de Olavide, Carretera de Utrera, km. 1, 41013 Seville, Spain.ORCID 0000-0001-9766-0627
Marcos Eguiguren HuertaDirector Chair in Sustainable Finance, UPF Barcelona School of Management, 08008 Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biomimicry is a scientific discipline that aims to model the behavior or properties of biological systems so as to adapt them to other scientific areas. Recently, this approach has been adopted in order to develop an organizational model called "Organizational Biomimicry". It proposes a systemic approach, a worldview that places the organization and the people related to it as an integral part of nature, and an R&D system based on continuous learning from nature. The effective management of this business model depends on leaders who can make dynamic decisions, generate commitment to the views of the company, define specific goals, actively learn on multiple levels and tackle conflicts. This type of leadership may actually be being exercised in business practice; however, no leadership style inspired by biomimicry has been theorized to date. Thus, the aim of this research was to present a biomimetic leadership model that considers nature as a model, measure and mentor. To this end, we proposed, firstly, a definition of a biomimetic leader from the point of view of the characteristics of biomimetic organizations. Then, we determined the characteristics of this leadership type. Secondly, we conducted a review of the main leadership styles analyzed in the recent literature about management; then, for each leadership type, we extracted the characteristics that will adapt to the biomimetic leadership model. From this process, we obtained the traits of a biomimetic leader. This characterization (definition plus characteristics) was subjected to an expert panel, which determined its validity.

Indexed as

biomimetic leadershipleadershiporganizational biomimicry

Identifiers

PMID34287236
PMCPMC8293048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.